MDL request for Onglyza Lawsuits
MDL request for Onglyza Lawsuits

Introduction
The U.S. Judicial Panel on Multidistrict Litigation was approached by a group of Plaintiffs to centralize Onglyza cases in a single federal court, alleging they suffered heart failure due to Onglyza. The outcome maybe positive as there is definitely a growing number of federally-filed cases, each showing marked similarity in allegations against the manufacturer AstraZeneca.
Latest News
Cencora Directors Settle Opioid Oversight Case for $111M
Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids…
Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients
A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…
FDA Adds New Warnings on Long-Term Opioid Risks
Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.
…